Economy

Most Recent Analysts Ratings Horizon Pharma plc (HZNP)

Some buy side analysts are also providing their Analysis on Horizon Pharma plc, where 4 analysts have rated the stock as Strong buy, 6 analysts have given a Buy signal, 2 said it's a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. The relative volume of the stock is 0.53, while its market cap is $2.25 Billion. It has underperformed by 44.83% the S&P500. The CCI technical indicator can be used to help determine if a stock is overbought or oversold. To make the technical rating meaningful, the moving averages are also compared to each other.

05/08/2017 - Horizon Pharma, Inc. had its "outperform" rating reiterated by analysts at Cowen.

07/14/2016 - Horizon Pharma, Inc. had its "buy" rating reiterated by analysts at Brean Capital. The firm has "Buy" rating by Mizuho given on Monday, December 14.

Colliers International Group Inc.is engaged in the provision of commercial real estate services. Broadfin Capital Llc bought 3.06 million shares as the company's stock declined 38.11% while stock markets rallied. It has a 26.11 P/E ratio. The Company's divisions include Americas; Europe, Middle East and Africa; Asia Pacific, and Corporate. Entercom Communications Corp. (ETM) has declined 15.65% since October 20, 2016 and is downtrending. About 1.20 million shares traded.

Investors sentiment decreased to 0.92 in Q2 2017. Its down 0.10, from 1.02 in 2017Q1. Amalgamated Bank grew its stake in shares of Horizon Pharma PLC by 4.8% in the 2nd quarter. 130.94 million shares or 1.72% less from 133.24 million shares in 2017Q1 were reported. 127,000 were reported by State Of Wisconsin Board. Cornerstone has 847 shares. Finally, Cantor Fitzgerald reissued a "buy" rating and issued a $17.00 price objective on shares of Horizon Pharma PLC in a research report on Tuesday, September 26th. Deerfield Mngmt Co accumulated 9.00 million shares. Horizon Pharma PLC had a negative net margin of 42.40% and a positive return on equity of 22.85%.

Horizon Pharma PLC (NASDAQ:HZNP) was downgraded by Zacks Investment Research from a "hold" rating to a "sell" rating in a research report issued to clients and investors on Tuesday, October 10th. 162,900 are owned by Tekla Cap Management Limited Liability.

TRADEMARK VIOLATION NOTICE: "Horizon Pharma PLC (HZNP) Rating Increased to Buy at ValuEngine" was originally posted by BBNS and is owned by of BBNS. Bank of Montreal Can lifted its position in Horizon Pharma PLC by 16.3% during the second quarter. BidaskClub raised Horizon Pharma PLC from a hold rating to a buy rating in a research report on Saturday, June 24th. Geode Capital Management Limited Com has invested 0.01% in Horizon Pharma PLC (NASDAQ:HZNP).

More interesting news about Horizon Pharma PLC (NASDAQ:HZNP) were released by: Globenewswire.com and their article: "Horizon Pharma plc Appoints Pascale Witz and James Shannon, MD to Board of ..." published on August 03, 2017 as well as Globenewswire.com's news article titled: "Horizon Pharma plc Announces Michelle Parsons as a 2017 Healthcare ..." with publication date: May 11, 2017. The Company's marketed medicines are ACTIMMUNE (interferon gamma-1b), BUPHENYL (sodium phenylbutyrate) Tablets and Powder, DUEXIS (ibuprofen/famotidine), KRYSTEXXA (pegloticase), MIGERGOT (ergotamine tartrate & caffeine suppositories), PENNSAID (diclofenac sodium topical solution) 2% weight per weight (w/w), or PENNSAID 2%, PROCYSBI (cysteamine bitartrate) delayed-release capsules, QUINSAIR (aerosolized form of levofloxacin), RAVICTI (glycerol phenylbutyrate) Oral Liquid, RAYOS (prednisone) delayed-release tablets and VIMOVO (naproxen/esomeprazole magnesium). The Firm is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. It now has negative earnings.

Since May 10, 2017, it had 1 buying transaction, and 0 insider sales for $94,800 activity. Another trade for 10,000 shares valued at $94,800 was bought by GREY MICHAEL G.

In case of Revenue Estimates, 10 analysts have provided their consensus Average Revenue Estimates for Horizon Pharma plc as 259.74 Million. Horizon Pharma PLC has a 52-week low of $9.45 and a 52-week high of $21.98. The rating was maintained by Citigroup with "Neutral" on Tuesday, August 9. The rating was initiated by Goldman Sachs with "Buy" on Thursday, December 17. They now have a Dollars 18 price target on the stock.

10/22/2015 - Horizon Pharma, Inc. had its "buy" rating reiterated by analysts at JMP Securities. The company was maintained on Tuesday, February 28 by Mizuho. The Average True Range is an investor tool used to measure stock volatility.



Like this

loading...
loading...

Latest


21 October 2017
(NYSE:NRZ) Rating Reiterated by FBR & Co
Moreover, California Pub Employees Retirement Sys has 0% invested in Independent Bank Group Inc (NASDAQ:IBTX) for 6,100 shares. American Assets Capital Advisers increased New Residential Invt Corp (NRZ) stake by 79.4% reported in 2017Q2 SEC filing.

21 October 2017
Runners-up Juventus topped Champions League payments, Leicester edges Real Madrid
Leicester City earned more money than Real Madrid for their participation in last season's UEFA Champions League. Of 32 group-stage teams, Basel's €16.3m was the lowest share of nearly €1.4 billion in the UEFA prize fund.

21 October 2017
Mash The Gas: NASCAR Playoffs At Kansas Speedway Preview
The 2015 champion carried a whopping 41 points into the second round, more than any other driver not named Martin Truex Jr . A similar showing - based off where Johnson and Blaney (two points ahead of Johnson) finish could be enough to advance.

21 October 2017
Weak iPhone 8 demand drags Apple shares lower
The minor improvements could be one of the reasons that users have made a decision to keep their iPhone 7. To compare, the iPhone 8 and iPhone 8 Plus start at $699 and $799, respectively.

21 October 2017
Get your flu shots early, says Sask. chief medical health officer
Shahab said despite the vaccine becoming more available, the number of people getting the shot has been on the decline. Pharmacists can only immunize adults and children, nine years or older, who have a valid Saskatchewan health card.

21 October 2017
Texas Woman Suffered Broken Heart Syndrome after Dog Died
Doctors instead diagnosed Simpson with Takotsubo cardiomyopathy, a condition with symptoms that mimic heart attacks. But when the dog was diagnosed with congenital heart failure, Simpson decided it was best to have her euthanized.

21 October 2017
Hurricanes and earthquakes will cost insurance industry £72bn
In September, Hurricane Irma struck the Florida Keys archipelago and Hurricane Maria slammed into Puerto Rico. Earlier this week, JP Morgan Chase & Co has issued a CHF103 target and a buy rating on the company.

21 October 2017
The NEXT Financial Group Inc Buys 50 Shares of SAP SE (SAP)
Stock repurchase programs are generally a sign that the company's leadership believes its shares are undervalued. Sustainable Growth Advisers LP increased its stake in shares of SAP SE by 9.1% in the second quarter.

21 October 2017
AK Steel Holding Corporation (NYSE:AKS) Quarterly Analytical Analysis
Over the last three months, the shares of the company have changed -2.58% and performed -10.12% over the last six months. Beta is a measurement of the stock price fluctuation, and may be used to gauge how fast the price may rise or fall.

21 October 2017
Domestic violence vigil held for victims in Birmingham
His sister, Ellen Gregory Robb, was killed by her husband, a University of Pennsylvania professor, three days before Christmas in 2006.